Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

The ISARIC4C Investigators, The COVID-19 Genomics UK (COG-UK) Consortium, Emma C. Thomson, Laura E. Rosen, James G. Shepherd, Roberto Spreafico, Ana da Silva Filipe, Jason A. Wojcechowskyj, Chris Davis, Luca Piccoli, David J. Pascall, Josh Dillen, Spyros Lytras, Nadine Czudnochowski, Rajiv Shah, Marcel Meury, Natasha Jesudason, Anna De Marco, Kathy Li, Jessica BassiAine O'Toole, Dora Pinto, Rachel M. Colquhoun, Katja Culap, Ben Jackson, Fabrizia Zatta, Andrew Rambaut, Stefano Jaconi, Vattipally B. Sreenu, Jay Nix, Ivy Zhang, Ruth F. Jarrett, William G. Glass, Martina Beltramello, Kyriaki Nomikou, Matteo Pizzuto, Lily Tong, Elisabetta Cameroni, Tristan I. Croll, Natasha Johnson, Julia Di Iulio, Arthur Wickenhagen, Alessandro Ceschi, Aoife M. Harbison, Daniel Mair, Paolo Ferrari, Katherine Smollett, Federica Sallusto, Stephen Carmichael, Christian Garzoni, Jenna Nichols, Massimo Galli, David L. Robertson*, Gyorgy Snell*, Matthew Bashton, Darren Smith, Andrew Nelson, Greg Young

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

274 Citations (Scopus)
233 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds